Amgen (AMGN) Change in Taxes (2009 - 2026)

Amgen has reported Change in Taxes for 18 years, with the latest figure at -$131.0 million in Q2 2026.

• On a quarterly basis, Change in Taxes rose 94.58% year-over-year to -$131.0 million in Q2 2026; TTM through Jun 2026 was $185.0 million, a 109.19% increase from a year earlier, with the FY2025 full-year figure at -$2.1 billion, down 104.55% from the prior year.
• Change in Taxes was -$131.0 million for Q2 2026 at Amgen, down from $71.0 million in the prior quarter.
• The five-year high for Change in Taxes was $610.0 million in Q3 2025, with the low at -$2.4 billion in Q2 2025.
• Average Change in Taxes over 5 years is -$267.6 million, with a median of $62.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Change in Taxes surged 511.54% in 2022, then sank 5578.57% in 2024.
• Over 5 years, Change in Taxes stood at -$155.0 million in 2022, then plunged by 1209.03% to -$2.0 billion in 2023, then surged by 102.61% to $53.0 million in 2024, then sank by 788.68% to -$365.0 million in 2025, then surged by 64.11% to -$131.0 million in 2026.
• The last three Change in Taxes figures came in at -$131.0 million (Q2 2026), $71.0 million (Q1 2026), and -$365.0 million (Q4 2025), per Business Quant data.